GNRSU stock down 99.999% on 02 Feb 2026 (The Greenrose, PNK): liquidity risk

GNRSU stock plunged about 99.999% to $0.000001 on 02 Feb 2026 during market hours on the PNK exchange in the United States. The Greenrose Holding Company Inc. (GNRSU) showed a previous close of $0.15 and intraday volume of 145 shares, signaling a near-total collapse in quoted price. We examine the drivers: quoted micro-price, thin liquidity, the company’s reported EPS of $3.10, and what this means for investors and risk management.

Price action and market data for GNRSU stock

GNRSU stock is trading at $0.000001 with a one-day change of -99.999% versus a previous close of $0.15. Market capitalization reads about $13.00, and reported volume today was 145 shares. The year high stands at $0.15 and the year low at $0.000001. This price pattern shows severe quote compression and very limited tradable liquidity on PNK.

Financials and valuation metrics for The Greenrose Holding Company Inc.

The Greenrose Holding Company Inc. reports EPS of $3.10 and book value per share of $4.30. Reported ratios include a PE that effectively rounds to 0.00 given the micro share price, and a price-to-book near 0.00 on the quote. Key metrics show negative working capital of -103434000.00 and cash per share of $0.56, highlighting a mismatch between accounting metrics and market quotation.

Liquidity, volume and trading risks

Trading today shows only 145 shares changing hands and an average volume not reported, which creates material execution risk. Low volume and a micro price mean single trades can move the quote dramatically. Investors face wide spreads, unreliable price discovery, and higher odds of order failure or delisting on PNK.

Sector context and peer comparison in Healthcare cannabis space

Greenrose operates in the Healthcare sector, industry Drug Manufacturers – Specialty & Generic, focused on cannabis production. Peers in the sector trade at materially higher liquidity and price levels; GNRSU’s micro-quote separates it from listed cannabis peers and increases relative volatility. Sector pressures and regulatory nuance for cannabis add execution and regulatory risk to GNRSU exposure.

Meyka AI rates GNRSU with a score out of 100 and outlook

Meyka AI rates GNRSU with a score out of 100: 63.07 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects solid historical profitability metrics but penalizes market liquidity and balance sheet working capital. These grades are not guaranteed and are informational only.

Analyst-style price forecast and scenario outlook for GNRSU stock

Meyka AI’s forecast model projects scenario-based targets: a base case of $0.01, a bullish recovery near the 52-week high of $0.15, and a downside where the quoted micro-price persists at $0.000001. From the current quote of $0.000001, the base case implies an upside of roughly 999900.00% to $0.01. Forecasts are model-based projections and not guarantees.

Final Thoughts

Key takeaways for GNRSU stock: the quoted market price of $0.000001 on 02 Feb 2026 reflects extreme liquidity stress rather than a gradual valuation move. The Greenrose Holding Company Inc. shows positive accounting EPS of $3.10 and book value per share of $4.30, but those metrics are separate from tradability on PNK. Trading volume today was only 145 shares and market cap near $13.00, which creates large execution and quote risk. Meyka AI’s grade of 63.07 (B, HOLD) balances solid company metrics against market and working capital concerns. Our scenario forecasts include a base-case $0.01 target and a bull-case near $0.15, each compared to the current micro-price; these imply very large percentage moves but depend entirely on restored liquidity and market confidence. For traders, GNRSU presents high volatility, low liquidity and potential delisting or spread blowouts. For longer-term investors, watch regulatory developments, company disclosures, and volume recovery before increasing exposure. Meyka AI, an AI-powered market analysis platform, flags liquidity and valuation mismatch as the primary risk drivers and notes that forecasts are projections, not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.